Advancing Point News Today

UMass Chan Medical School and UMass Lowell have received an $8.9 million award from the National Institutes of Health (NIH) for renewed support of their initiative to advance the development of home-based and point-of-care health technologies.

Yorba Linda, CA (PRWEB) March 16, 2023 -- Yorba Linda, CA (May 16, 2023) - Labroots, the leading scientific social networking website, offering premier,

Oak Ridge, TN, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces...

Six new products poised to improve the quality of health care will take center stage at a June event for life sciences innovators and investors reshaping the industry.

Life sciences entrepreneurs, researchers and investors working to shape the future of point-of-care medical technologies will gather next week for a free virtual event that will highlight new inventions and connect participants to resources to advance their work.

UMass Medical School helps lead NIH RADx to accelerate new COVID test technologies Project has increased U.S. testing capacity by more than 180 million tests By Susan E.W. Spencer April 01, 2021 While the acceleration of COVID-19 vaccinations has received much attention, the national effort to bring convenient, affordable and rapid testing technology for SARS-CoV-2 infection to market is also moving full speed ahead. In addition to the original mission to mak...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES ... Daxor CorporationFebruary 5, 2021 GMT NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has been awarded a grant from the Center for Advancing Point of Care Technologies (CAPCaT), a program run by the...

Top story: UMass Medical School receives $100 million in NIH grants to lead push for fast, accessible COVID-19 tests By Susan E.W. Spencer December 28, 2020 As this unprecedented year comes to a close, the Office of Communications is rerunning some of the big stories of 2020 that highlight the incredible work of the UMass Medical School community. From the first-in-the-nation early graduation of our medical students to the essential clinical research that lea...

Top story: NIH research funding surges at UMass Medical School COVID studies drive 78 percent first quarter spike in federal funding over last year UMass Medical School Communications December 21, 2020 As this unprecedented year comes to a close, the Office of Communications is rerunning some of the big stories of 2020 that highlight the incredible work of the UMass Medical School community. From the first-in-the-nation early graduation of our medical students to the essential clini...

Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2 CINCINNATI, Dec. 16, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been awarded funding in the amount of approximately $1M by the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx SM) initiative, to expedite the launch of the company...